Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Conditions:   Carcinoma;   Intrahepatic Cholangiocarcinoma;   Digestive System Neoplasms;   PD-1 Inhibitor;   First-line Treatment Interventions:   Drug: Pemigatinib;   Drug: PD-1 Inhibitors Sponsors:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   First Affiliated Hospital of Jinan University;   Shenzhen University General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials